0001127602-12-011999.txt : 20120328 0001127602-12-011999.hdr.sgml : 20120328 20120328161513 ACCESSION NUMBER: 0001127602-12-011999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120326 FILED AS OF DATE: 20120328 DATE AS OF CHANGE: 20120328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haluska Frank CENTRAL INDEX KEY: 0001494892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 12720818 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-03-26 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001494892 Haluska Frank C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 SVP, Clinical R&D, CMO Common Stock 2012-03-26 4 M 0 3000 2.39 A 48531 D Common Stock 2012-03-26 4 S 0 3000 16.00 D 45531 D Employee Stock Option (Right to Buy) 2.39 2012-03-26 4 M 0 3000 0 D 2009-06-12 2018-06-12 Common Stock 3000 22500 D Shares were acquired upon the exercise of outstanding stock options at $2.39 per share. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-03-27